VHCP MANAGEMENT, LLC
3340 HILLVIEW AVENUE, PALO ALTO, California, 94304, (650) 475-3734
Report Date: 03/31/2013
Position Statistics:
| Total Positions | 16 |
| New Positions | 2 |
| Increased Positions | 3 |
| Decreased Positions | 5 |
| Positions with Activity | 8 |
| Sold Out Positions | 1 |
| Total Mkt Value (in $ millions) |
133 |
Sector Weighting
| Basic Materials | |
| Capital Goods | |
| Conglomerates | |
| Consumer Cyclical | |
| Consumer/Non-Cyclical | |
| Energy | |
| Financial | |
| Healthcare | 100% |
| Services | |
| Technology | |
| Transportation | |
| Utilities |
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.
16 Positions as of 03/31/2013
| Company | Class |
Value of Shares ($1,000s) | Change in Value ($1,000s) | Change (%) | Shares Held |
|---|---|---|---|---|---|
| AMICUS THERAPEUTICS INC | COM | 559 | 559 | New | 164,000 |
| ANACOR PHARMACEUTICALS INC | COM | 9,117 | New | 1,610,856 | |
| ANTHERA PHARMACEUTICALS INC | COM | 834 | New | 1,437,623 | |
| BIOCRYST PHARMACEUTICALS | COM | 672 | New | 392,990 | |
| CHELSEA THERAPEUTICS INTL LTD | COM | 4,631 | New | 2,516,870 | |
| DYAX CORP | COM | 3,366 | 3,366 | New | 1,335,714 |
| GTX INC DEL | COM | 9,930 | -1,980 | (16.63) | 1,773,242 |
| HYPERION THERAPEUTICS INC | COM | 5,518 | 108 | 2 | 255,000 |
| KERYX BIOPHARMACEUTICALS INC | COM | 16,267 | -4,602 | (22.05) | 2,048,773 |
| NEUROCRINE BIOSCIENCES INC | COM | 23,596 | -3,090 | (11.58) | 1,964,673 |
| TESARO INC | COM | 23,317 | New | 656,813 | |
| IRONWOOD PHARMACEUTICALS INC | COM CL A | 24,894 | -8,298 | (25) | 1,800,000 |
| ALEXZA PHARMACEUTICALS INC | COM NEW | 2,225 | New | 499,999 | |
| BIODEL INC | COM NEW | 4,179 | New | 1,274,000 | |
| REPROS THERAPEUTICS INC | COM NEW | -5,723 | Sold Out | 0 | |
| THRESHOLD PHARMACEUTICAL INC | COM NEW | 3,748 | New | 684,000 |
Latest News Headlines
QIWI to Announce First Quarter 2013 Financial Results on June 4, 2013 4:01PM ET - GlobeNewswire
Exa Corporation Announces Date of First Quarter Fiscal 2014 Financial Results Conference Call and W 4:01PM ET - GlobeNewswire
Cyclacel Pharmaceuticals Announces Closing of Underwritten Offering 4:01PM ET - GlobeNewswire
UBIC, Inc. Announces Closing of Its U.S. Initial Public Offering of American Depositary Shares 4:00PM ET - GlobeNewswire
UPDATE: Wal-Mart, Costco, Other Merchants Push Back Against Swipe-Fee Settlement 3:52PM ET - Dow Jones Business News
View All